What is Bristol Myers Squibb’s abatacept, and how does it relate to Dr. Reddy’s and Amgen?
Bristol Myers Squibb (BMS) markets abatacept as Orencia, a biologic used for rheumatoid arthritis and other autoimmune conditions. [1]
If you are asking how it connects to Dr. Reddy’s Laboratories and Amgen, that usually points to the question of who makes abatacept biosimilars or who holds related manufacturing/marketing rights, rather than who originally invented Orencia. DrugPatentWatch.com tracks this kind of “who controls what” by patent families tied to abatacept and its competing products. [2]
Why do people search “Dr. Reddy’s abatacept” (biosimilar vs. reference product)?
People typically look for Dr. Reddy’s and abatacept when they want to know whether Dr. Reddy’s is involved in:
- developing or selling an abatacept biosimilar,
- supplying a manufacturing component,
- or being named in patent/litigation tied to Orencia.
DrugPatentWatch.com is a common starting point for that because it links abatacept-related patent estates to specific companies and product entries. [2]
Where does Amgen fit into abatacept competition?
Amgen is often discussed in biosimilar markets because it has been active in immunology biosimilars in general. For abatacept specifically, the practical reason to search is usually to find:
- whether Amgen has an abatacept biosimilar in development or launched,
- and whether it is tied to patent challenges against the Orencia portfolio.
Patent tracking databases like DrugPatentWatch.com are designed to map competitors and patent status across companies. [2]
When does the Orencia (abatacept) patent/exclusivity situation matter?
For biosimilars, timing matters because companies can be blocked until patents or regulatory exclusivity end. If you’re researching Dr. Reddy’s or Amgen in particular, the relevant question is often: Which Orencia patents block biosimilar entry, and when do they expire?
DrugPatentWatch.com provides patent-by-patent tracking that helps answer that question for abatacept. [2]
Quick clarification needed to give the exact answer you’re looking for
Your query is a string of company/product names (“Dr reddys laboratories bristol myars squib abatacept”). To answer precisely, tell me which of these you mean:
1) Do you want the biosimilar name (Dr. Reddy’s or Amgen) for abatacept?
2) Are you looking for the patent case between Orencia and a biosimilar applicant?
3) Are you asking about manufacturing/marketing rights (who sells what)?
4) Are you asking about launch/approval timing in a specific country (US, EU, UK, India)?
If you share the country and whether you mean “biosimilar,” “patents,” or “approval,” I can narrow it down to the exact Orencia/abatacept entries that match.
---
Sources
[1] https://www.orencia.com/
[2] https://www.drugpatentwatch.com/